Follow
Jonathan Moss
Jonathan Moss
Unknown affiliation
Verified email at midway.uchicago.edu
Title
Cited by
Cited by
Year
Herbal medicines and perioperative care
MK Ang-Lee, J Moss, CS Yuan
Jama 286 (2), 208-216, 2001
13872001
Plasma catecholamines in stress and exercise
JE Dimsdale, J Moss
Jama 243 (4), 340-342, 1980
7671980
Nutrition in the acute phase of critical illness
MP Casaer, G Van den Berghe
New England Journal of Medicine 370 (13), 1227-1236, 2014
4092014
Histamine release during morphine and fentanyl anesthesia
CE Rosow, J Moss, DM Philbin, JJ Savarese
Survey of Anesthesiology 26 (6), 342-343, 1982
4081982
Methylnaltrexone for reversal of constipation due to chronic methadone use: a randomized controlled trial
CS Yuan, JF Foss, M O'Connor, J Osinski, T Karrison, J Moss, MF Roizen
Jama 283 (3), 367-372, 2000
3782000
Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial
JK Han, C Bachert, W Fokkens, M Desrosiers, M Wagenmann, SE Lee, ...
The Lancet Respiratory Medicine 9 (10), 1141-1153, 2021
3442021
Brief communication: American ginseng reduces warfarin's effect in healthy patients: a randomized, controlled trial
CS Yuan, G Wei, L Dey, T Karrison, L Nahlik, S Maleckar, K Kasza, ...
Annals of Internal Medicine 141 (1), 23-27, 2004
3342004
Short-Term Catecholamine Response to Psychological Stress1
JE Dimsdale, J Moss
Psychosomatic Medicine 42 (5), 493-497, 1980
2961980
The novel role of the mu opioid receptor in lung cancer progression: a laboratory investigation
B Mathew, FE Lennon, J Siegler, T Mirzapoiazova, N Mambetsariev, ...
Anesthesia & Analgesia 112 (3), 558-567, 2011
2872011
Methylnaltrexone prevents morphine‐induced delay in oral‐cecal transit time without affecting analgesia: a double‐blind randomized placebo‐controlled trial
CS Yuan, JF Foss, M O'Connor, A Toledano, MF Roizen, J Moss
Clinical Pharmacology & Therapeutics 59 (4), 469-475, 1996
2731996
Predictors of body surface area
Y Wang, J Moss, R Thisted
Journal of clinical anesthesia 4 (1), 4-10, 1992
2611992
Nitric oxide accounts for dose-dependent estrogen-mediated coronary relaxation after acute estrogen withdrawal.
P Collins, J Shay, C Jiang, J Moss
Circulation 90 (4), 1964-1968, 1994
2511994
The safety and efficacy of oral methylnaltrexone in preventing morphine‐induced delay in oral‐cecal transit time
CS Yuan, JF Foss, J Osinski, A Toledano, MF Roizen, J Moss
Clinical Pharmacology & Therapeutics 61 (4), 467-475, 1997
2211997
Methylnaltrexone inhibits opiate and VEGF-induced angiogenesis: role of receptor transactivation
PA Singleton, MW Lingen, MJ Fekete, JGN Garcia, J Moss
Microvascular research 72 (1-2), 3-11, 2006
2202006
Histamine release by narcotics and muscle relaxants in humans
J Moss, CE Rosow
The Journal of the American Society of Anesthesiologists 59 (4), 330-339, 1983
2021983
The Mu opioid receptor promotes opioid and growth factor-induced proliferation, migration and Epithelial Mesenchymal Transition (EMT) in human lung cancer
FE Lennon, T Mirzapoiazova, B Mambetsariev, VA Poroyko, R Salgia, ...
PloS one 9 (3), e91577, 2014
2002014
C5a and thromboxane generation associated with pulmonary vaso-and broncho-constriction during protamine reversal of heparin.
DR Morel, WM Zapol, SJ Thomas, EM Kitain, DR Robinson, J Moss, ...
Anesthesiology 66 (5), 597-604, 1987
1971987
Overexpression of the μ-opioid receptor in human non-small cell lung cancer promotes Akt and mTOR activation, tumor growth, and metastasis
FE Lennon, T Mirzapoiazova, B Mambetsariev, R Salgia, J Moss, ...
The Journal of the American Society of Anesthesiologists 116 (4), 857-867, 2012
1902012
The use of H1 and H2 histamine antagonists with morphine anesthesia: a double-blind study.
DM Philbin, J Moss, CW Akins, CE Rosow, K Kono, RC Schneider, ...
Anesthesiology 55 (3), 292-296, 1981
1881981
Use of methylnaltrexone and related compounds
JF Foss, MF Roizen, J Moss, CS Yuan, W Drell
US Patent 5,972,954, 1999
185*1999
The system can't perform the operation now. Try again later.
Articles 1–20